2-Naphthalenecarboxylic acid, 3-hydroxy-, 2-[(3,4-dihydroxyphenyl)methylene]hydrazide – (304448-55-3)

BTYNB, 304456-62-0, 2-(((5-Bromothiophen-2-yl)methylene)amino)benzamide, Benzamide, 2-[[(5-bromo-2-thienyl)methylene]amino]-, MDK6620, 2-[(5-bromothiophen-2-yl)methylideneamino]benzamide, 2-{[(E)-(5-bromothiophen-2-yl)methylidene]amino}benzamide, 2-{[(5-bromo-2-thienyl)methylene]amino} benzamide, 2-[(E)-[(5-BROMOTHIOPHEN-2-YL)METHYLIDENE]AMINO]BENZAMIDE, BTYNB IMP1 Inhibitor, TimTec1_002386, SCHEMBL10090730, HMS1540M10, MFCD00977636, s9871, STK014922, AKOS000484586, AKOS040759630, BS-48808, DA-71795, HY-124447, CS-0086494, E85137, 2-((5-Bromothiophen-2-yl)methyleneamino)benzamide, 2-{[(5-Bromothien-2-yl)methylene]amino}benZamide, SR-01000204166, 2-[[(5-bromo-2-thienyl)methylene]amino]-benzamide, SR-01000204166-1, (E)-2-(((5-Bromothiophen-2-yl)methylene)amino)benzamide